Skip to main content
Premium Trial:

Request an Annual Quote

Cenix to Provide Research Services to Debiopharm

Premium

Cenix BioScience this week announced that it has signed an agreement to provide its research services to Swiss drugmaker Debiopharm.

Under the deal, Cenix will use its high-throughput screening and high-content assay know-how to identify predictive biomarkers for Debiopharm’s preclinical oncology candidates.

“Multi-parametric microscopy-based readouts established by Cenix … will be used in a range of human cancer cell models to identify genes and pathways that either enhance or suppress the drug's therapeutic effects,” the company said.

Specific terms of the arrangement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.